From: Exploring the therapeutic potential of isoorientin in the treatment of osteoporosis: a study using network pharmacology and experimental validation
Targets
PDBID
Mode
Affinity (kcal/mol)
Akt1
3MVH
1
− 10.0
MAPK1
2Y9Q
− 8.8
2
− 9.5
− 7.8
3
− 9.3
− 7.7
4
5
− 9.1
− 7.6
6
− 8.9
7
− 7.5
8
9
− 8.1